CEBPA and hepatocellular carcinoma: Zeng C. et al. have shown that C/EBPα transactivates the miR-122 gene by directly binding to at least two different sites on its promoter, indicating that the reduction in C/EBPα activity leads to the downregulation of miR-122 in HCC [201] (Figure 7).